Santaris Pharma A/S
Utilizing its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine capabilities, Roche Innovation Center Copenhagen aims to deliver effective and well tolerated RNA-targeted therapies that have the ability to inhibit and cure diseases and to improve the quality of life of patients with critical diseases where options are inadequate or do not exist.